Why does CIMIT not support pharmaceutical development?
CIMIT recognizes that the development of new pharmaceutical agents is generally well supported by major industrial labs, while the underlying basic research is supported by the NIH, both at much larger scales than CIMIT. This is also true of the general fields of surface chemistry and coatings. CIMIT has, however, actively supported the development and demonstration of devices for the local delivery of pharmaceutical agents, and, on occasion, agents to improve the contrast of imaging systems when the project is multidisciplinary. Also, CIMIT has supported multidisciplinary teams seeking new approaches to tissue engineering and wound healing.
